Novartis Ag (NVS) Other Non-Current Assets (2009 - 2026)

Novartis Ag (NVS) posted Other Non-Current Assets of $200.0 million for Q1 2026, down 60.71% sequentially from $509.0 million in Q4 2025.

Novartis Ag (NVS) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Novartis Ag (NVS) has 14 years of Other Non-Current Assets data on file, last reported at $200.0 million in Q1 2026.

  • Quarterly Other Non-Current Assets changed N/A year-over-year to $200.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.0 million (changed N/A YoY) and the FY2025 annual result came in at $509.0 million, down 85.48% from the prior year.
  • Other Non-Current Assets declined to $200.0 million in Q1 2026 per NVS's latest filing, from $509.0 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $4.5 billion in Q2 2025, with the low at $200.0 million in Q1 2026.
  • Average Other Non-Current Assets over 5 years is $2.0 billion, with a median of $1.2 billion recorded in 2023.
  • Year-over-year, Other Non-Current Assets jumped 303.64% in 2022 and plunged 85.48% in 2025.
  • Novartis Ag's Other Non-Current Assets stood at $1.1 billion in 2022, then climbed by 8.02% to $1.2 billion in 2023, then surged by 192.33% to $3.5 billion in 2024, then sank by 85.48% to $509.0 million in 2025, then plunged by 60.71% to $200.0 million in 2026.
  • Business Quant data shows NVS's Other Non-Current Assets at $200.0 million in Q1 2026, $509.0 million in Q4 2025, and $4.5 billion in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.23 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 14.11 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 10.54 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 19.81 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.76 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 4.55 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 9.83 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 200.00 Mn
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 777.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 200.00 Mn
Dec 31, 2025 509.00 Mn
Jun 30, 2025 4.47 Bn
Dec 31, 2024 3.51 Bn
Jun 30, 2024 1.66 Bn
Dec 31, 2023 1.20 Bn
Jun 30, 2023 1.21 Bn
Dec 31, 2022 1.11 Bn
Jun 30, 2022 3.89 Bn
Dec 31, 2021 275.00 Mn
Jun 30, 2021 2.21 Bn
Dec 31, 2020 892.00 Mn
Sep 30, 2020 850.00 Mn
Jun 30, 2020 866.00 Mn
Mar 31, 2020 988.00 Mn
Dec 31, 2019 738.00 Mn
Sep 30, 2019 689.00 Mn
Jun 30, 2019 703.00 Mn
Mar 31, 2019 626.00 Mn
Dec 31, 2018 895.00 Mn